-
Benzinga's Upgrade Summary for June 7, 2012
Thursday, June 7, 2012 - 12:29pm | 600Listed below are today's Top Upgrades covered by Benzinga: Bank of America Upgrades Sonic (NASDAQ: SONC) to Buy: Bank of America comments, "We are raising our rating on Sonic shares from Underperform to Buy following impressive May quarter sales. The stock is currently trading at about a 25-30%...
-
UPDATE: Taglich Brothers Upgrades UFP Technologies to Speculative Buy on Attractive Valuation
Thursday, June 7, 2012 - 7:46am | 110Taglich Brothers raises its rating on UFP Technologies (NASDAQ: UFPT) from Neutral to Speculative Buy and establishes a price target of $18.50 a share. Taglich Brothers comments, "The company's revenue growth has slowed over the past three quarters due to the loss of a significant portion of a...
-
Taglich Brothers Maintains Buy Rating On Lifeway Foods
Thursday, June 2, 2011 - 8:38am | 189According to Taglich Brothers, Lifeway Foods (NASDAQ: LWAY) Buy rating is maintained. Taglich Brothers said that it is maintaining its Speculative Buy rating on shares of Lifeway Foods, Inc. (NasdaqGM: LWAY) and 12-month price target of $12.15 per share. “Our price target is based on a historic...
-
Taglich Brothers Has Speculative Buy On CTI Industries Corporation
Wednesday, May 25, 2011 - 7:36am | 105Taglich Brothers has a Speculative Buy rating on shares of CTI Industries Corporation (NASDAQ: CTIB), but is lowering its price target to $6.25. In a note to clients, Taglich writes, "We are maintaining our investment rating of Speculative Buy on CTI Industries Corporation (CTIB: NASDAQ CM) but...
-
Taglich Brothers Give Update On ASYS
Wednesday, May 25, 2011 - 7:27am | 130Taglich Brothers is maintaining its Buy rating and its $35.50 price target on Amtech Systems (NASDAQ: ASYS) in light of 2Q11 results. In the report, Taglich Brothers writes, “ASYS reported 2Q11 EPS (May 10, 2011) of $0.77 on revenue of $61.3 million. Results were significantly better than 1Q10 and...
-
Taglich Brothers Neutral On Pressure BioSciences, Inc.
Wednesday, May 25, 2011 - 7:15am | 140Taglich Brothers has a Neutral rating on shares of Pressure BioSciences, Inc. (NASDAQ: PBIO). In a note to clients, Taglich writes, "We are maintaining our Neutral rating on Pressure BioSciences (NasdaqCM: PBIO) due to heightened concerns about the company's ability to raise sufficient capital to...
-
Taglich Brothers Maintains Rating, PT On DARA
Tuesday, May 17, 2011 - 9:01am | 154Taglich Brothers is maintaining its Speculative Buy rating and its $7.15 price target on DARA BioSciences Inc. (NASDAQ: DARA) as it looks to the future of the company's pipeline drugs. Says Taglich, in the report, “DARA's lead pipeline drugs address the markets for neuropathic pain and Type 2...
-
Taglich Brothers Initiates Lakeland Industries, Inc.
Tuesday, September 7, 2010 - 9:35am | 135Taglich Brothers, Inc. announces that it has initiated coverage of Lakeland Industries, Inc. (NASDAQ: LAKE). Lakeland Industries, Inc., headquartered in Ronkonkoma, New York, manufactures and sells a comprehensive line of safety garments and accessories for the industrial protective clothing...
-
Taglich Brothers Initiates Lakeland Industries, Inc.
Tuesday, September 7, 2010 - 9:34am | 135Taglich Brothers, Inc. announces that it has initiated coverage of Lakeland Industries, Inc. (NASDAQ: LAKE). Lakeland Industries, Inc., headquartered in Ronkonkoma, New York, manufactures and sells a comprehensive line of safety garments and accessories for the industrial protective clothing...